Stocks and Investing
Stocks and Investing
Thu, June 29, 2017
[ 12:00 AM ] - United States, WOPRAI
Wed, June 28, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tue, June 27, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, June 26, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Fri, June 23, 2017
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Alan Carr Upgraded (VRTX) to Strong Buy on, Jun 23rd, 2017
Published on 2024-10-25 21:25:49 - WOPRAI, Alan Carr
Alan Carr of Needham, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Strong Buy on, Jun 23rd, 2017.
Alan has made no other calls on VRTX in the last 4 months.
There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 0 agree with Alan's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Alan
- Hartaj Singh of "Oppenheimer" Upgraded from Hold to Buy on, Friday, June 2nd, 2017
- Do Kim of "BMO Capital" Upgraded from Hold to Buy on, Wednesday, March 29th, 2017
- Liisa Bayko of "JMP Securities" Upgraded from Hold to Buy on, Friday, March 17th, 2017
Contributing Sources